Rephonic
Artwork for Oncology Today

Oncology Today with Dr Neil Love

Dr. Neil Love
Immunotherapy
Clinical Trials
Breast Cancer
Antibody-Drug Conjugates
PARP Inhibitors
Prostate Cancer
Non-Hodgkin Lymphoma
Multiple Myeloma
Colorectal Cancer
Ovarian Cancer
Chronic Lymphocytic Leukemia
CAR T-Cell Therapy
Chemotherapy
Endometrial Cancer
Bispecific Antibodies
Follicular Lymphoma
Gastroesophageal Cancer
BTK Inhibitors
Non-Small Cell Lung Cancer
Metastatic Breast Cancer

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

PublishesDailyEpisodes412Founded6 years ago
Number of ListenersCategories
ScienceMedicineHealth & Fitness

Listen to this Podcast

Artwork for Oncology Today

Latest Episodes

Dr Arvind Dasari from the University of Texas MD Anderson Cancer Center in Houston and Dr Anwaar Saeed from UPMC Hillman Cancer Center in Pittsburgh, Pennsylvania, discuss key clinical trial data regarding the management of colorectal cancer.

CME in... more

YouTube

Professor Thomas Powles from Barts Cancer Institute in London, United Kingdom, discusses recent developments with circulating tumor DNA assays in the management of urothelial bladder cancer.

CME information and select publications here.

YouTube

Dr Jennifer R Brown and Prof Wojciech Jurczak discuss the selection and sequencing of Bruton tyrosine kinase-targeted therapy for patients with chronic lymphocytic leukemia and summarize major advances in the treatment landscape over the past year. more

YouTube

Prof Nicoletta Colombo from the European Institute of Oncology IRCCS in Milan, Italy, Dr Alexander Olawaiye from the University of Pittsburgh School of Medicine in Pennsylvania, Dr Gottfried Konecny from the University of California, Los Angeles and ... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Dr Wassim Abida
Memorial Sloan Kettering Cancer Center
Episode: PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida
Jonathan Letterman
Professor, UCL Cancer Institute, London
University College London
Episode: Immunotherapy for Endometrial Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancer
Ursula Matulonis
Dr., Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Episode: Immunotherapy for Endometrial Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancer
Angela Secord
Dr., Duke Cancer Institute
Duke Cancer Institute
Episode: Immunotherapy for Endometrial Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancer
Dr Nikhil Khushalani
Medical oncologist from Moffitt Cancer Center
Moffitt Cancer Center
Episode: Oncology Nursing Update: Nonmelanoma Skin Cancers — An Interview with Dr Nikhil Khushalani
Dr. Chris Liu
Moderator from the University of Colorado Cancer Center
University of Colorado Cancer Center
Episode: Localized Colorectal Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Dr. Jenny Seligmann
Professor
University of Leeds
Episode: Localized Colorectal Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Dr. Stacey Cohn
Faculty member
Fred Hutchinson Cancer Center, University of Washington
Episode: Localized Colorectal Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Dr. Cohen
Faculty member
Episode: Localized Colorectal Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

Host

Neil Love
Multiple episode host with affiliations to Research To Practice and Oncology Today-related programs; central figure guiding many interviews.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#243
Saudi Arabia/Science
Apple Podcasts
#244
Russia/Science

Talking Points

Recent interactions between the hosts and their guests.

Oncology Nursing Update: Nonmelanoma Skin Cancers — An Interview with Dr Nikhil Khushalani
Q: How do you approach combining hedgehog inhibitors with immunotherapy in basal cell carcinoma?
The typical approach is upfront hedgehog inhibition, with immunotherapy considered if patients are intolerant or progress. Emerging data suggest potential sequencing strategies, and trials are exploring combinations, though results so far have not shown clear synergistic benefits in this setting.
Oncology Nursing Update: Nonmelanoma Skin Cancers — An Interview with Dr Nikhil Khushalani
Q: What are the key toxicity considerations with checkpoint inhibitors in this patient population?
Autoimmune toxicities are a major consideration but are generally manageable. Common side effects include fatigue, rash, diarrhea, and thyroid dysfunction; severe toxicities like myocarditis or endocrine crises are rare but require rapid recognition and management, often with steroids or immunosuppressants as needed.
Oncology Nursing Update: Nonmelanoma Skin Cancers — An Interview with Dr Nikhil Khushalani
Q: Can you summarize how sensitive these tumors are to immunotherapy and when you would use it in the disease course?
Nonmelanoma skin cancers tend to be highly immunogenic due to high tumor mutational burden, leading to relatively high response rates to anti-PD-1 therapies. We use immunotherapy upfront in locally advanced or unresectable cases and also in adjuvant settings for high-risk disease, with careful consideration of potential toxicities, especially in older patients.
Localized Colorectal Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Q: Would you consider skipping chemotherapy entirely and using immunotherapy for certain patients with MSI-high or poli-mutant tumors?
There is cautious consideration for immunotherapy in select MSI-high patients, especially when CTDNA suggests minimal disease burden, but overall consensus emphasizes careful patient selection and recognizing that definitive evidence supporting universal omission of chemotherapy is lacking; some experts would opt for immunotherapy in specific high-risk elderly patients or CTDNA-positive cases, but not as a broad replacement.
Localized Colorectal Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Q: What are some of the clinical pathologic features that most strongly influenced your recommendation for adjuvant therapy in MSI-high disease?
The panel indicates that MSI-high status, T4 features, and overall TNM context shape adjuvant decisions, with consideration of the tumor's biology and the potential toxicity of chemotherapy, and whether CTDNA negative status might sway toward less aggressive adjuvant chemotherapy in some cases, though the default remains to offer standard therapy unless clear biomarkers suggest otherwise.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Oncology Today

What is Oncology Today about and what kind of topics does it cover?

Medical oncology-focused conversations feature in-depth interviews and panel discussions with leading cancer researchers and clinicians. Episodes emphasize practical decision-making in biomarker-driven therapy, targeted agents, immunotherapy, and emerging diagnostic technologies, often anchored by real patient cases and community oncologist perspectives. Across samples, themes include PARP inhibitors in prostate cancer, ctDNA/MRD-guided colorectal cancer strategies, and the integration of novel agents (e.g., CELMoDs, antibody-drug conjugates) into front-line and relapse settings. Notable is the strong emphasis on translating trial data into everyday practice, including testing strategies, sequencing decisions, toxicity management, and the e... more

Where can I find podcast stats for Oncology Today?

Rephonic provides a wide range of podcast stats for Oncology Today. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Oncology Today and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Oncology Today get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Oncology Today, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Oncology Today?

Rephonic provides comprehensive predictive audience data for Oncology Today, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Oncology Today have?

To see how many followers or subscribers Oncology Today has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Oncology Today?

These podcasts share a similar audience with Oncology Today:

1. Two Onc Docs
2. Research To Practice | Oncology Videos
3. Oncology Brothers: Practice-Changing Cancer Discussions
4. Breast Cancer Update
5. OncLive® On Air

How many episodes of Oncology Today are there?

Oncology Today launched 6 years ago and published 412 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Oncology Today?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Oncology Today?

Rephonic pulls ratings and reviews for Oncology Today from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Oncology Today?

Rephonic provides full transcripts for episodes of Oncology Today. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Oncology Today?

Recent guests on Oncology Today include:

1. Dr Wassim Abida
2. Jonathan Letterman
3. Ursula Matulonis
4. Angela Secord
5. Dr Nikhil Khushalani
6. Dr. Chris Liu
7. Dr. Jenny Seligmann
8. Dr. Stacey Cohn

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days